Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > Neuropsychiatry: psychoses that should not always be treated with antipsychotics

Neuropsychiatry: psychoses that should not always be treated with antipsychotics

Yury P. Sivolap , Anna A. Portnova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Disorders manifested by both neurological and mental disorders belong to the neuropsychiatric diseases. This category includes Alzheimer's disease, Parkinson's disease, Wernicke–Korsakoff syndrome, delirium tremens, catatonia and anti-NMDA receptor encephalitis. The etiology of psychotic disorders in neuropsychiatric diseases probably differs from that in schizophrenia and other psychoses, which causes both inefficiency and adverse events when using antipsychotics in neuropsychiatry. In the absence of a therapeutic alternative, antipsychotics can be prescribed with caution for neurodegenerative disorders, whereas catatonia is a relative, and anti-NMDA receptor encephalitis is an absolute contraindication to their use.
Keywords: neuropsychiatry, Alzheimer’s disease, Parkinson’s disease, Wernicke–Korsakoff syndrome, delirium tremens, catatonia, schizophrenia, anti-NMDA receptor encephalitis, antipsychotics, clozapine, pimavanserin, benzodiazepines, lorazepam, electroconvulsive therapy.

About the Author

Yury P. Sivolap 1 , Anna A. Portnova 1

1 Patrice Lumumba Peoples’ Friendship University of Russia, Moscow, Russia

References

1. Koponen M, Taipale H, Lavikainen P et al. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy among Community-Dwelling Persons with Alzheimer's Disease. J Alzheimers Dis 2017;56(1):107-18. DOI: 10.3233/JAD-160671
2. Koponen M, Taipale H, Lavikainen P et al. Antipsychotic Use and the Risk of Hip Fracture among Community-Dwelling Persons with Alzheimer's Disease. J Clin Psychiatry 2017;78(3):e257-e263. DOI: 10.4088/JCP.15m10458
3. Koponen M, Rajamaki B, Lavikainen P et al. Antipsychotic Use and Risk of Stroke among Community-Dwelling People with Alzheimer's Disease. J Am Med Dir Assoc 2022;23(6):1059-1065.e4. DOI: 10.1016/j.jamda.2021.09.036
4. Dyer AD, Murphy C, Lawlor B, Kennelly SP for The Nilvad Study Group. Long-term antipsychotic use and cognitive decline in community-dwelling older adults with mild-moderate Alzheimer disease: Data from NILVAD. Int J Geriatr Psychiatry 2021;36(11):1708-21. DOI: 10.1002/gps.5591
5. Yunusa I, Rashid N, Seyedin R et al. Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-Analysis. J Geriatr Psychiatry Neurol 2023;36(5):417-32. DOI: 10.1177/08919887231154933
6. Srisurapanont M, Suradom C, Suttajit S et al. Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis. Gen Hosp Psychiatry 2024;87:124-33. DOI: 10.1016/j.genhosppsych.2024.02.008
7. Palm A, Talaslahti T, Vataja R et al. Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke-Korsakoff Syndrome: A Nationwide Register Study in Finland. J Clin Med 2023;12(13):4263. DOI: 10.3390/jcm12134263
8. Kaye AD, Staser AN, Mccollins TS et al. Delirium Tremens: A Review of Clinical Studies. Cureus 2024;16(4):e57601. DOI: 10.7759/cureus. 57601
9. Dalmau J, Armangué T, Planagumà J et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 2019;18(11):1045-57. DOI: 10.1016/S1474-4422(19)30244-3
10. Lee KW, Khan AHKY, Ching SM et al. Prevalence and Factor Associated with Anti-N-Methyl-D-Aspartate Receptor Encephalitis Among Patients with Medical Conditions: A Systematic Review and Meta-Analysis. Neurol India 2024;72(3):476-86. DOI: 10.4103/neuroindia. NI_981_20
11. Valente T, Gonçalves G, Duarte V, Jesus G. Anti-N-Methyl-D-Aspartate Receptor Encephalitis, A Diagnosis not to Miss. Eur J Case Rep Intern Med 2023;10(8):003974. DOI: 10.12890/2023_003974
12. Kahlbaum KL. Die Katatonie oder das Spannungsirresein. Berlin: Verlag von August Hirschwald, 1874.
13. Hirjak D, Rogers JP, Wolf RC et al. Catatonia. Nat Rev Dis Primers 2024;10(1):49. DOI: 10.1038/s41572-024-00534-w
14. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 2010;36(2):314-20. DOI: 10.1093/schbul/sbp059
15. Appiani FJ, Castro GS. Catatonia is not schizophrenia and it is treatable. Schizophr Res 2018;200:112-6. DOI: 10.1016/j.schres.2017.05.030
16. Van Den Eede F, Van Hecke J, Van Dalfsen A et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005;20(5-6):422-9. DOI: 10.1016/j.eurpsy.2005.03.012
17. Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull 2010;36(2):239-42. DOI: 10.1093/schbul/sbp141
18. Hirjak D, Sartorius A, Kubera KM, Wolf RC. Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon. Mol Psychiatry 2021;26(11):6112-4. DOI: 10.1038/s41380-021-01158-2
19. Lloyd JR, Silverman ER, Kugler JL, Cooper JJ. Electroconvulsive therapy for patients with catatonia: Current perspectives. Neuropsychiatr Dis Treat 2020;(16):2191-208. DOI: 10.2147/NDT.S231573
20. Beach SR, Gomez-Bernal F, Huffman JC, Fricchione GL. Alternative treatment strategies for catatonia: A systematic review. Rev Gen Hosp Psychiatry 2017;(48):1-19. DOI: 10.1016/j.genhosppsych.2017.06.011

For citation:Sivolap Y.P., Portnova A.A. Neuropsychiatry: psychoses that should not always be treated with antipsychotics. Clinical review for general practice. 2024; 5 (8): 6–11. (In Russ.). DOI: 10.47407/kr2024.5.8.00453


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru